Company intelligence / Profile preview

NorthView

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Consulting and investment with expertise in capital markets, product development, launch, and lifecycle management for therapeutics, devices, and diagnostics. Some affiliated active projects include novel monoclonal antibodies, targeted radiotherapies, and specialty ophthalmology drugs

Therapeutic areas: OphthalmologyGastroenterologyCardiovascularOtherOncologyNeurology
Modalities: Monoclonal antibodyTargeted alpha radiation therapySmall moleculePeptidesLive biotherapeutic productDeviceSoftwareNanoparticle
Industry: Consulting

Partnerships

Aequus PharmaceuticalsResolution DiagnosticsNeovascIco TherapeuticsSynaptive MedicalAlabasterPerimeter Medical Imaging

Beyond the preview

Go deeper on NorthView.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NorthView.

Explore the full profile